약물전달 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,194,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,571,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,325,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

약물전달 기기 시장의 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 약물전달 기기 세계 시장 규모는 2025-2030년에 걸쳐 7.5%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상되며, 2030년까지 6,674억 달러에 이를 전망입니다.

암, 신경질환, 당뇨병, 기타 감염증의 유병률 증가가 향후 수년간에 있어서의 드러그 딜리버리 디바이스의 채택을 촉진할 것으로 예상되고 있습니다. 또, 안과, 신경학, 종양학 등 다양한 용도용의 제품 발매 증가도 시장 성장을 가속할 것으로 보여지고 있습니다. 홈케어 환경에서 사용할 수 있는 웨어러블 약물 전달 장치의 채택이 증가함에 따라 시장도 주도할 것으로 예상됩니다.

하이드로겔은 유명한 약물 전달 차량 중 하나이며, 초분자 하이드로겔, DNA 하이드로겔, 바이오인스파이어드 하이드로겔, 다기능 하이드로겔, 자극 반응성 하이드로겔 등을 포함합니다. 이 첨단 하이드로겔은 안과, 경구, 장, 심장 질환, 암 등 다양한 용도로 사용되고 있습니다.

시장에 존재하는 주요 참가 기업은 다양한 용도의 약물전달 기기를 개발 및 개량하기 위해 M&A, 제휴, 공동 개발 등 다양한 전략을 채택하고 있습니다. 그리고 조사 연구를 위해 약물전달 기기를 입수하고 있으며, 시장 진출기업은 자사 제품의 리치를 확대하기 위해 판매 계약을 맺고 있습니다.

약물전달 기기 시장 보고서 하이라이트

• 흡입기 부문은 천식 치료 수요에 견인되어 2024년에는 23.9%의 점유율로 시장을 선도했습니다.
• 당뇨병용 약물전달 기기 부문은 2024년에 21.1%의 점유율로 시장을 독점했습니다.
• 2024년 시장 점유율은 병원 부문이 29.0%로 최대를 차지하고, 외과적 개입이나 예방 처치 수요 증가에 견인되었습니다.
• 북미의 약물전달 기기 시장은 세계 시장 전체를 지배해, 2024년의 매출액 점유율은 32.4%였습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 약물전달 기기 시장의 변수, 동향, 범위

• 시장 계통의 전망
  • 모 시장 전망
  • 관련, 부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 약물전달 기기 시장 분석 툴
  • 산업 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 약물전달 기기 시장 : 제품별, 추정 및 예측 분석

• 부문 대시보드
• 약물전달 기기 시장 : 제품 변동 분석
• 약물전달 기기 시장 :제품별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 흡입기
• 주사장치
• 임플란트
• 국소 전달 시스템
• 경구 투여 시스템
• 안과용 전달 시스템
• 분무기
• 경피 패치
• 주입 펌프

제5장 약물전달 기기 시장 : 용도별, 추정 및 예측 분석

• 부문 대시보드
• 약물전달 기기 시장 : 용도 변동 분석
• 약물전달 기기 시장 : 용도별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 종양학
• 감염증
• 호흡기 질환
• 당뇨병
• 심혈관 질환
• 자가면역질환
• 중추 신경계 질환
• 기타

제6장 약물전달 기기 시장 : 최종 용도별, 추정 및 예측 분석

• 부문 대시보드
• 약물전달 기기 시장 : 최종 용도 변동 분석
• 약물전달 기기 시장 : 최종 용도별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 병원
• 진단센터
• 외래수술센터(ASC), 클리닉
• 재택 케어
• 기타

제7장 약물전달 기기 시장 :지역별, 추정 및 예측 분석

• 지역 대시보드
• 지역별 약물전달 기기 시장 변동 분석
• 약물전달 기기 시장 : 유통 채널과 최종 용도에 의한 지역 추정 및 예측 분석
• 2018-2030년 시장 규모와 예측과 동향 분석
• 북미
  • 미국
  • 캐나다
  • 멕시코
  • 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 시장 진출기업의 분류
• 주요 기업 프로파일
  • Gerresheimer AG
  • WL Gore & Associates, Inc.
  • Abbott
  • Terumo Medical Corporation
  • Stryker
  • Medtronic
  • Boston Scientific Corporation
  • Novartis AG
  • Becton, Dickinson and Company
  • Teleflex Incorporated

SHW

영문 목차

영문목차

Drug Delivery Devices Market Growth & Trends:

The global drug delivery devices market size is expected to reach USD 667.4 billion by 2030, registering a CAGR of 7.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing prevalence of cancer, neurological disorders, diabetes, and other infectious diseases is expected to drive the adoption of drug delivery devices in the coming years. In addition, increasing product launches for various applications such as ophthalmology, neurology, and oncology are also expected to propel the market growth. Growing adoption of wearable drug delivery devices for its usage in home-care settings is also expected to drive the market.

Hydrogel is one of the prominent drug delivery vehicles and includes supramolecular hydrogels, DNA hydrogels, bio-inspired hydrogels, multi-functional and stimuli-responsive hydrogels. These advanced hydrogels are used for various applications such as ophthalmic, oral, intestinal, cardiac illness, and cancer. Similarly, other vehicles such as liposomes, nanoparticles, and micelle are also being developed for various applications.

Key players present in the market are adopting various strategies such as mergers and acquisitions, partnership, and collaborations to develop and improve drug delivery devices for various applications. Moreover, end-users are also forming partnerships with companies to acquire drug delivery devices for training purpose and research studies. In addition, market players are also forming distribution agreement to expand the reach of their products. Therefore, alliances made by the players are expected to drive the market growth during the forecast period.

Drug Delivery Devices Market Report Highlights:

• The inhalers segment leads the market with a share of 23.9% in 2024, driven by the demand for asthma treatment. However, conventional metered-dose inhalers contribute significantly to greenhouse gas emissions.
• The drug delivery devices segment for diabetes dominated the market in 2024 with a share of 21.1%.
• The hospitals segment held the largest market share in 2024 with a share of 29.0%, driven by the rising demand for surgical interventions and preventive procedures.
• The North America drug delivery devices market dominated the overall global market and accounted for the 32.4% revenue share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.21. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End-use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing demand for novel drug delivery devices
    • 3.2.1.2. Increasing prevalence of chronic diseases
    • 3.2.1.3. Technological advancement in drug delivery devices
    • 3.2.1.4. Growing strategic alliances for drug delivery devices
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Challenges associated with various routes of drug delivery devices
• 3.3. Drug Delivery Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Drug Delivery Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Drug Delivery Devices Market: Product Movement Analysis
• 4.3. Drug Delivery Devices Market by Product Outlook (USD Billion)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Inhalers
  • 4.5.1. Inhalers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.5.1.1. Metered-dose inhalers (MDIs)
      • 4.5.1.1.1. Metered-dose inhalers (MDIs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.5.1.2. Dry powder inhalers (DPIs)
      • 4.5.1.2.1. Dry powder inhalers (DPIs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.5.1.3. Others
      • 4.5.1.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.6. Injection Devices
  • 4.6.1. Injection Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.1.1. Prefilled Syringes
      • 4.6.1.1.1. Prefilled Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.1.2. Auto-injectors
      • 4.6.1.2.1. Auto-injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.1.3. Pen Injectors
      • 4.6.1.3.1. Pen Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.1.4. Needle-free Injectors
      • 4.6.1.4.1. Needle-free Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.1.5. Wearable Injectors
      • 4.6.1.5.1. Wearable Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.7. Implants
  • 4.7.1. Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.7.1.1. Contraceptive Implants
      • 4.7.1.1.1. Contraceptive Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.7.1.2. Drug-eluting Stents
      • 4.7.1.2.1. Drug-eluting Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.7.1.3. Biodegradable Implants
      • 4.7.1.3.1. Biodegradable Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.8. Topical Delivery System
  • 4.8.1. Topical Delivery System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.8.1.1. Creams
      • 4.8.1.1.1. Creams Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.8.1.2. Gels
      • 4.8.1.2.1. Gels Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.8.1.3. Ointments
      • 4.8.1.3.1. Ointments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.9. Oral Delivery System
  • 4.9.1. Oral Delivery System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.9.1.1. Controlled-release Tablets and Capsules
      • 4.9.1.1.1. Controlled-release Tablets and Capsules Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.9.1.2. Buccal and Sublingual Tablets
      • 4.9.1.2.1. Buccal and Sublingual Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.10. Occular Delivery System
  • 4.10.1. Occular Delivery System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.11. Nebulizers
  • 4.11.1. Nebulizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.12. Transdermal Patches
  • 4.12.1. Transdermal Patches Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.13. Infusion Pumps
  • 4.13.1. Infusion Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Drug Delivery Devices Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Drug Delivery Devices Market: Application Movement Analysis
• 5.3. Drug Delivery Devices Market by Application Outlook (USD Billion)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Oncology
  • 5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.6. Infectious Diseases
  • 5.6.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.7. Respiratory Diseases
  • 5.7.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.8. Diabetes
  • 5.8.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.9. Cardiovascular Diseases
  • 5.9.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.10. Autoimmune Diseases
  • 5.10.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.11. Central Nervous System Disorders
  • 5.11.1. Central Nervous System Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.12. Others
  • 5.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Drug Delivery Devices Market: End-use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Drug Delivery Devices Market: End-use Movement Analysis
• 6.3. Drug Delivery Devices Market by End-use Outlook (USD Billion)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.6. Diagnostic Centers
  • 6.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.7. Ambulatory Surgery Centers/Clinics
  • 6.7.1. Ambulatory Surgery Centers/Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.8. Home Care Settings
  • 6.8.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.9. Others
  • 6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Drug Delivery Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Drug Delivery Devices Market Movement Analysis
• 7.3. Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Distribution Channel & End-use
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.5. Europe
  • 7.5.6. Europe Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.7. UK
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. UK Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.8. Germany
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Reimbursement scenario
    • 7.5.8.5. Germany Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.9. France
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Reimbursement scenario
    • 7.5.9.5. France Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.10. Italy
    • 7.5.10.1. Key Country Dynamics
    • 7.5.10.2. Competitive Scenario
    • 7.5.10.3. Regulatory Framework
    • 7.5.10.4. Reimbursement scenario
    • 7.5.10.5. Italy Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.11. Spain
    • 7.5.11.1. Key Country Dynamics
    • 7.5.11.2. Competitive Scenario
    • 7.5.11.3. Regulatory Framework
    • 7.5.11.4. Reimbursement scenario
    • 7.5.11.5. Spain Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.12. Denmark
    • 7.5.12.1. Key Country Dynamics
    • 7.5.12.2. Competitive Scenario
    • 7.5.12.3. Regulatory Framework
    • 7.5.12.4. Reimbursement scenario
    • 7.5.12.5. Denmark Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.13. Sweden
    • 7.5.13.1. Key Country Dynamics
    • 7.5.13.2. Competitive Scenario
    • 7.5.13.3. Regulatory Framework
    • 7.5.13.4. Reimbursement scenario
    • 7.5.13.5. Sweden Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.14. Norway
    • 7.5.14.1. Key Country Dynamics
    • 7.5.14.2. Competitive Scenario
    • 7.5.14.3. Regulatory Framework
    • 7.5.14.4. Reimbursement scenario
    • 7.5.14.5. Norway Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Japan Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. China Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. India Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. South Korea Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Australia Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Thailand Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 7.7. Latin America
  • 7.7.1. Latin America Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Brazil Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Argentina Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. South Africa Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Saudi Arabia Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. UAE Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Kuwait Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Gerresheimer AG
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. W. L. Gore & Associates, Inc.
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Abbott
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Terumo Medical Corporation
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Stryker
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Medtronic
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Boston Scientific Corporation
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Novartis AG
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Becton, Dickinson and Company
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Teleflex Incorporated
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives

관련자료